Abstract
The removal of intervening sequences from transcripts is catalyzed by the spliceosome, a multicomponent complex that assembles on the newly synthesized pre-mRNA. Pre-mRNA translation in the cytoplasm leads to the generation of aberrant proteins that are potentially harmful. Therefore, tight control to prevent undesired pre-mRNA export from the nucleus and its subsequent translation is an essential requirement for reliable gene expression. Here, we show that the natural product FR901464 (1) and its methylated derivative, spliceostatin A (2), inhibit in vitro splicing and promote pre-mRNA accumulation by binding to SF3b, a subcomplex of the U2 small nuclear ribonucleoprotein in the spliceosome. Importantly, treatment of cells with these compounds resulted in leakage of pre-mRNA to the cytoplasm, where it was translated. Knockdown of SF3b by small interfering RNA induced phenotypes similar to those seen with spliceostatin A treatment. Thus, the inhibition of pre-mRNA splicing during early steps involving SF3b allows unspliced mRNA leakage and translation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kramer, A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65, 367–409 (1996).
Padgett, R.A., Konarska, M.M., Grabowski, P.J., Hardy, S.F. & Sharp, P.A. Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors. Science 225, 898–903 (1984).
Ruskin, B., Krainer, A.R., Maniatis, T. & Green, M.R. Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38, 317–331 (1984).
Nagai, K. et al. Structure and assembly of the spliceosomal snRNPs. Novartis Medal Lecture. Biochem. Soc. Trans. 29, 15–26 (2001).
Black, D.L., Chabot, B. & Steitz, J.A. U2 as well as U1 small nuclear ribonucleoproteins are involved in premessenger RNA splicing. Cell 42, 737–750 (1985).
Mount, S.M., Pettersson, I., Hinterberger, M., Karmas, A. & Steitz, J.A. The U1 small nuclear RNA-protein complex selectively binds a 5′ splice site in vitro. Cell 33, 509–518 (1983).
Berglund, J.A., Chua, K., Abovich, N., Reed, R. & Rosbash, M. The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell 89, 781–787 (1997).
Zamore, P.D. & Green, M.R. Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc. Natl. Acad. Sci. USA 86, 9243–9247 (1989).
Gozani, O., Potashkin, J. & Reed, R. A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol. Cell. Biol. 18, 4752–4760 (1998).
Konarska, M.M. & Sharp, P.A. Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes. Cell 49, 763–774 (1987).
Pikielny, C.W., Rymond, B.C. & Rosbash, M. Electrophoresis of ribonucleoproteins reveals an ordered assembly pathway of yeast splicing complexes. Nature 324, 341–345 (1986).
Rutz, B. & Seraphin, B. Transient interaction of BBP/ScSF1 and Mud2 with the splicing machinery affects the kinetics of spliceosome assembly. RNA 5, 819–831 (1999).
Staley, J.P. & Guthrie, C. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 92, 315–326 (1998).
Galy, V. et al. Nuclear retention of unspliced mRNAs in yeast is mediated by perinuclear Mlp1. Cell 116, 63–73 (2004).
Maquat, L.E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1, 453–465 (1995).
Dziembowski, A. et al. Proteomic analysis identifies a new complex required for nuclear pre-mRNA retention and splicing. EMBO J. 23, 4847–4856 (2004).
Wang, Q., He, J., Lynn, B. & Rymond, B.C. Interactions of the yeast SF3b splicing factor. Mol. Cell. Biol. 25, 10745–10754 (2005).
Nakajima, H. et al. New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. (Tokyo) 49, 1196–1203 (1996).
Nakajima, H. et al. New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J. Antibiot. (Tokyo) 49, 1204–1211 (1996).
Nakajima, H., Kim, Y.B., Terano, H., Yoshida, M. & Horinouchi, S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res. 241, 126–133 (1998).
Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30, 630–641 (2005).
Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).
Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).
Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
Pagano, M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682–685 (1995).
Motoyoshi, H. et al. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes. Biosci. Biotechnol. Biochem. 68, 2178–2182 (2004).
Albert, B.J., Sivaramakrishnan, A., Naka, T., Czaicki, N.L. & Koide, K. Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue. J. Am. Chem. Soc. 129, 2648–2659 (2007).
Thompson, C.F., Jamison, T.F. & Jacobsen, E.N. FR901464: total synthesis, proof of structure, and evaluation of synthetic analogues. J. Am. Chem. Soc. 123, 9974–9983 (2001).
Krainer, A.R., Maniatis, T., Ruskin, B. & Green, M.R. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell 36, 993–1005 (1984).
Watakabe, A., Inoue, K., Sakamoto, H. & Shimura, Y. A secondary structure at the 3′ splice site affects the in vitro splicing reaction of mouse immunoglobulin mu chain pre-mRNAs. Nucleic Acids Res. 17, 8159–8169 (1989).
Reed, R. & Hurt, E. A conserved mRNA export machinery coupled to pre-mRNA splicing. Cell 108, 523–531 (2002).
O'Keefe, R.T., Mayeda, A., Sadowski, C.L., Krainer, A.R. & Spector, D.L. Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors. J. Cell Biol. 124, 249–260 (1994).
Misteli, T., Caceres, J.F. & Spector, D.L. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387, 523–527 (1997).
Tanackovic, G. & Kramer, A. Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo. Mol. Biol. Cell 16, 1366–1377 (2005).
Das, B.K. et al. Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol. Cell. Biol. 19, 6796–6802 (1999).
Ishida, N. et al. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277, 14355–14358 (2002).
Kudo, N. et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540–547 (1998).
Reed, R. & Magni, K. A new view of mRNA export: separating the wheat from the chaff. Nat. Cell Biol. 3, E201–E204 (2001).
Rutz, B. & Seraphin, B. A dual role for BBP/ScSF1 in nuclear pre-mRNA retention and splicing. EMBO J. 19, 1873–1886 (2000).
Abovich, N. & Rosbash, M. Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals. Cell 89, 403–412 (1997).
Nagy, E. & Maquat, L.E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci. 23, 198–199 (1998).
Maquat, L.E. & Li, X. Mammalian heat shock p70 and histone H4 transcripts, which derive from naturally intronless genes, are immune to nonsense-mediated decay. RNA 7, 445–456 (2001).
Gehring, N.H., Neu-Yilik, G., Schell, T., Hentze, M.W. & Kulozik, A.E. Y14 and hUpf3b form an NMD-activating complex. Mol. Cell 11, 939–949 (2003).
Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181–1189 (1999).
Fukuhara, T. et al. Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. USA 103, 11329–11333 (2006).
Hamamoto, T., Gunji, S., Tsuji, H. & Beppu, T. Leptomycins A and B, new antifungal antibiotics. I. Taxonomy of the producing strain and their fermentation, purification and characterization. J. Antibiot. (Tokyo) 36, 639–645 (1983).
Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489 (1983).
Acknowledgements
We thank A. Krainer (Cold Spring Harbor Laboratory) for pSP64-HβΔ6 and pμC3-C4, K. Nagata for kind advice regarding preparation of nuclear extracts, and A. Kulozik (University of Heidelberg) for the NMD detection system. We are grateful to the RIKEN Brain Science Institute's Research Resources Center for DNA sequencing analysis and mass spectrometry. This work was supported in part by the CREST Research Project, the Japan Science and Technology Agency, The Strategic Research Programs for R&D, RIKEN, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. SF3b image in Graphical Abstract from Golas et al. Science 300, 980–984 (2003). Reprinted with permission from AAAS.
Author information
Authors and Affiliations
Contributions
M.Y. is responsible for project planning and experimental design, with support from M.H., T.T. and S.H.; D.K. performed most of the experiments; H.M., K.I., H.W. and T.K. synthesized chemical compounds; E.T. carried out in vitro kinase assays; T.N. performed in vitro splicing assays; T.Y. carried out pilot study; H.N. prepared FR901464.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 and Supplementary Methods (PDF 2506 kb)
Rights and permissions
About this article
Cite this article
Kaida, D., Motoyoshi, H., Tashiro, E. et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3, 576–583 (2007). https://doi.org/10.1038/nchembio.2007.18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2007.18
This article is cited by
-
Structural differences between the closely related RNA helicases, UAP56 and URH49, fashion distinct functional apo-complexes
Nature Communications (2024)
-
RNA splicing dysregulation and the hallmarks of cancer
Nature Reviews Cancer (2023)
-
Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer
Cell Death & Disease (2023)
-
Shell protein composition specified by the lncRNA NEAT1 domains dictates the formation of paraspeckles as distinct membraneless organelles
Nature Cell Biology (2023)
-
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions
Current Oncology Reports (2023)